Pharmaceutical News

RSS

NICE guideline advises GPs to stop prescribing opioids for chronic pain

Published today, the first ever NICE guideline on the treatment of chronic pain has said that GPs should not prescribe opioids and other medicines like paracetamol to patients because they could be ‘harmful’ and cause addiction.

5 Aug 2020

HPV vaccination reduces risk of cervical cancer

Vaccination against the human papilloma virus (HPV) reduces the risk of a condition that often leads to cervical cancer, according to an analysis of Danish health registry data.

5 Aug 2020

Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients

Neutrolis, a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cells in the body, today announced the development of NTR-441, a first-in-class DNASE1L3 enzyme analog that has the potential to rapidly and systemically clear neutrophil extracellular traps for severe cases of COVID-19.

5 Aug 2020

Pharmacists look at deprescribing to reduce the risk of medicine-related harm

In an article published today in Australian Prescriber, pharmacist Michelle Liacos from Alfred Health in Melbourne, and her co-authors, look at stopping medicines when they are no longer needed to reduce the risk of medicine-related harm.

5 Aug 2020

Study shows link between selenium-deficient diet and paracetamol toxicity

A lack of the mineral selenium in the diet puts people at risk of paracetamol overdose, even when the painkiller is taken at levels claimed to be safe on the packaging, according to collaborative research emerging from the University of Bath and Southwest University in China.

5 Aug 2020

New computational model can help determine drug viability

About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn's disease, end up becoming resistant or unresponsive to it.

5 Aug 2020

DSI introduces new, hands-on opportunity for drug sponsors to learn from CMC and regulatory subject matter experts

Design Space InPharmatics, an Industry Leader in Regulatory Drug Development, today announced its latest innovative offering for emerging biotech drug sponsors.

From DSI, a PLG Company 4 Aug 2020

Non-adherence to prescription medicines is more common in younger U.S women

For patients, especially those living with chronic conditions, nonadherence to prescription medicines due to cost is a common problem.

4 Aug 2020

Artificial intelligence can increase effectiveness of drug repurposing for psychiatric disorders

Artificial intelligence can increase the effectiveness of drug repositioning or repurposing research, according to a study published in Translational Psychiatry.

3 Aug 2020

Darolutamide shows indication of considerable added benefit in prostate cancer

Up to now, adult men with non-metastatic castration-resistant prostate cancer (nmCRPC) at high risk of developing metastatic disease usually continued their conventional androgen deprivation therapy (ADT) while the cancer was observed for the occurrence of metastases (so-called watchful waiting).

3 Aug 2020

Cannabinoids may alter the effects of some prescription drugs

Cannabinoid-containing products may alter the effects of some prescription drugs, according to Penn State College of Medicine researchers.

3 Aug 2020

New head lice treatment receives FDA approval

The treatment, Xeglyze, was developed by Hatchtech, an Australian pharmaceutical company and will be commercialized by Dr Reddy's Laboratories.

3 Aug 2020

FDA approves CBD oral solution for treatment of seizures related to tuberous sclerosis complex

Today, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older.

31 Jul 2020

New article reviews poor life expectancy associated with treatment-resistant schizophrenia

The vast majority of reviews on psychotropic drugs is focused on the potential benefits that may have. However, the vulnerabilities induced by treatment need also to be considered.

31 Jul 2020

Botox injections can reduce depression, shows study

Botox, a medication derived from a bacterial toxin, is commonly injected to ease wrinkles, migraines, muscle spasms, excessive sweating and incontinence.

30 Jul 2020

Researchers to investigate real-world effects of new cystic fibrosis medications

Researchers at RCSI University of Medicine and Health Sciences are leading a new €3m study to investigate the real-world effects of the newest cystic fibrosis medications as they become available for people with CF.

30 Jul 2020

FDA issues warning letters to companies for illegally selling hangover remedies

Today, the U.S. Food and Drug Administration announced it has issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate or prevent hangovers, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

29 Jul 2020

Pilot study shows cholesterol-lowering medication improves function of coronary arteries

In a pilot study of people living with HIV or high levels of cholesterol, Johns Hopkins Medicine researchers found that a six-week course of a cholesterol-lowering medication improved the function of the coronary arteries that provide oxygen to the heart.

29 Jul 2020

Public health experts fear a hasty FDA signoff on vaccine

The vaccine trial that Vice President Mike Pence kicked off in Miami on Monday gives the United States the tiniest chance of being ready to vaccinate millions of Americans just before Election Day.

29 Jul 2020

$Researchers examine the implications of bisphosphonate drug holidays on fracture risk$

Researchers examine the implications of bisphosphonate drug holidays on fracture risk

Bisphosphonates have been shown to reduce the risk of osteoporotic fractures. To avoid possible side effects of long-term therapy, many patients take a drug holiday after several years of bisphosphonate therapy.

29 Jul 2020

Pharmaceutical News

NICE guideline advises GPs to stop prescribing opioids for chronic pain

HPV vaccination reduces risk of cervical cancer

Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients

Pharmacists look at deprescribing to reduce the risk of medicine-related harm

Study shows link between selenium-deficient diet and paracetamol toxicity

New computational model can help determine drug viability

DSI introduces new, hands-on opportunity for drug sponsors to learn from CMC and regulatory subject matter experts

Non-adherence to prescription medicines is more common in younger U.S women

Artificial intelligence can increase effectiveness of drug repurposing for psychiatric disorders

Darolutamide shows indication of considerable added benefit in prostate cancer

Cannabinoids may alter the effects of some prescription drugs

New head lice treatment receives FDA approval

FDA approves CBD oral solution for treatment of seizures related to tuberous sclerosis complex

New article reviews poor life expectancy associated with treatment-resistant schizophrenia

Botox injections can reduce depression, shows study

Researchers to investigate real-world effects of new cystic fibrosis medications

FDA issues warning letters to companies for illegally selling hangover remedies

Pilot study shows cholesterol-lowering medication improves function of coronary arteries

Public health experts fear a hasty FDA signoff on vaccine

Researchers examine the implications of bisphosphonate drug holidays on fracture risk

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News